OnKure Therapeutics, Inc. (OKUR)
Nasdaq: OKUR · CIK 0001637715 · United States
Every official OnKure Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open OKUR filings
OnKure Therapeutics, Inc. documents
- OnKure Therapeutics, Inc. 10-K 2026OKUR 10-K 2026: annual report for fiscal 2026
- OnKure Therapeutics, Inc. 10-K 2025OKUR 10-K 2025: annual report for fiscal 2025
- OnKure Therapeutics, Inc. 10-K 2024OKUR 10-K 2024: annual report for fiscal 2024
- OnKure Therapeutics, Inc. 10-K 2023OKUR 10-K 2023: annual report for fiscal 2023
- OnKure Therapeutics, Inc. 10-K 2022OKUR 10-K 2022: annual report for fiscal 2022
- OnKure Therapeutics, Inc. 10-Q 2026OKUR 10-Q 2026: quarterly report for fiscal 2026
- OnKure Therapeutics, Inc. 10-Q 2025OKUR 10-Q 2025: quarterly report for fiscal 2025
- OnKure Therapeutics, Inc. 10-Q 2024OKUR 10-Q 2024: quarterly report for fiscal 2024
- OnKure Therapeutics, Inc. 10-Q 2023OKUR 10-Q 2023: quarterly report for fiscal 2023
- OnKure Therapeutics, Inc. 10-Q 2022OKUR 10-Q 2022: quarterly report for fiscal 2022
- OnKure Therapeutics, Inc. 8-K 2026OKUR 8-K 2026: current report for fiscal 2026
- OnKure Therapeutics, Inc. 8-K 2025OKUR 8-K 2025: current report for fiscal 2025
- OnKure Therapeutics, Inc. 8-K 2024OKUR 8-K 2024: current report for fiscal 2024
- OnKure Therapeutics, Inc. 8-K 2023OKUR 8-K 2023: current report for fiscal 2023
- OnKure Therapeutics, Inc. 8-K 2022OKUR 8-K 2022: current report for fiscal 2022
- OnKure Therapeutics, Inc. DEF 14A 2026OKUR DEF 14A 2026: proxy statement for fiscal 2026
- OnKure Therapeutics, Inc. DEF 14A 2025OKUR DEF 14A 2025: proxy statement for fiscal 2025
- OnKure Therapeutics, Inc. DEF 14A 2024OKUR DEF 14A 2024: proxy statement for fiscal 2024
- OnKure Therapeutics, Inc. DEF 14A 2023OKUR DEF 14A 2023: proxy statement for fiscal 2023
- OnKure Therapeutics, Inc. DEF 14A 2022OKUR DEF 14A 2022: proxy statement for fiscal 2022
- OnKure Therapeutics, Inc. Form 4 2026OKUR Form 4 2026: insider trading filing for fiscal 2026
- OnKure Therapeutics, Inc. Form 4 2025OKUR Form 4 2025: insider trading filing for fiscal 2025
- OnKure Therapeutics, Inc. Form 4 2024OKUR Form 4 2024: insider trading filing for fiscal 2024
- OnKure Therapeutics, Inc. Form 4 2023OKUR Form 4 2023: insider trading filing for fiscal 2023
- OnKure Therapeutics, Inc. Form 4 2022OKUR Form 4 2022: insider trading filing for fiscal 2022
- OnKure Therapeutics, Inc. S-1 2026OKUR S-1 2026: registration statement for fiscal 2026
- OnKure Therapeutics, Inc. S-1 2025OKUR S-1 2025: registration statement for fiscal 2025
- OnKure Therapeutics, Inc. S-1 2024OKUR S-1 2024: registration statement for fiscal 2024
- OnKure Therapeutics, Inc. S-1 2023OKUR S-1 2023: registration statement for fiscal 2023
- OnKure Therapeutics, Inc. S-1 2022OKUR S-1 2022: registration statement for fiscal 2022
- OnKure Therapeutics, Inc. 13F 2026OKUR 13F 2026: institutional holdings for fiscal 2026
- OnKure Therapeutics, Inc. 13F 2025OKUR 13F 2025: institutional holdings for fiscal 2025
- OnKure Therapeutics, Inc. 13F 2024OKUR 13F 2024: institutional holdings for fiscal 2024
- OnKure Therapeutics, Inc. 13F 2023OKUR 13F 2023: institutional holdings for fiscal 2023
- OnKure Therapeutics, Inc. 13F 2022OKUR 13F 2022: institutional holdings for fiscal 2022
More companies